1. 2OPan-genome cfDNA methylation analysis of metastatic prostate cancer. (7th November 2019) Authors: Wu, A; Cremaschi, P; Wetterskog, D; Conteduca, V; Franceschini, G M; Gonzalez-Billalebeita, E; Giorgi, U D; Demichelis, F; Lise, S; Attard, G Journal: Annals of oncology Issue: Volume 30(2019)Supplement 7 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 814PPlatinum-based therapy in men with metastatic castration resistant prostate (mCRPC) with or without DNA repair defects: A multicentre retrospective analysis. (23rd October 2018) Authors: Gillessen, S; Schmid, S; Beltran, H; Almeida, D V P; Mehra, N; Lavaud, P; Morales Barrera, R; Pignataro, D; Castro Marcos, E; Conteduca, V; Efstathiou, E; Le, H M L; Pezaro, C V; Suzuki, H; Zivi, A; Klingbiel, D; Omlin, A G Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 839PClinico-genomic profiling and outcome prediction of neuroendocrine prostate cancer (NEPC). (23rd October 2018) Authors: Conteduca, V; Oromendia, C; Sigouros, M; Sborner, A; Nanus, D M; Tagawa, S T; Ballman, K; Beltran, H Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗